Therapeutic challenges and cardiovascular risk in patients with HMGCR-associated immune-mediated necrotizing myopathy (HMGR-IMNM) secondary to statins

Eur J Intern Med. 2023 May 11:S0953-6205(23)00165-6. doi: 10.1016/j.ejim.2023.05.011. Online ahead of print.NO ABSTRACTPMID:37179139 | DOI:10.1016/j.ejim.2023.05.011
Source: European Journal of Internal Medicine - Category: Internal Medicine Authors: Source Type: research